182 related articles for article (PubMed ID: 37872086)
1. [Expert consensus on precise diagnosis and management of primary hepatocellular carcinoma in advanced stage (2023 version)].
; ;
Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):910-920. PubMed ID: 37872086
[TBL] [Abstract][Full Text] [Related]
2. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
Cheng S; Chen M; Cai J;
Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
[TBL] [Abstract][Full Text] [Related]
3. [Expert consensus on clinical diagnosis and treatment of portal hypertension with hepatocellular carcinoma (2022)].
Chinese Society of Spleen and Portal Hypertension Surgery, Chinese Society of Surgery, Chinese Medical Association
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):310-320. PubMed ID: 35272421
[TBL] [Abstract][Full Text] [Related]
4. [Chinese multidisciplinary expert consensus on combined immunotherapy for hepatocellular carcinoma(2023 version)].
; ;
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):16-34. PubMed ID: 36948846
[TBL] [Abstract][Full Text] [Related]
5. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma in the era of immunotherapy.
Sim HW; Knox J
Curr Probl Cancer; 2018; 42(1):40-48. PubMed ID: 29150141
[TBL] [Abstract][Full Text] [Related]
7. [Multidisciplinary experts consensus on diagnosis and treatment of precancerous lesions of hepatocellular carcinoma (2023 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1250-1261. PubMed ID: 38253068
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hepatocellular carcinoma.
Liccioni A; Reig M; Bruix J
Dig Dis; 2014; 32(5):554-63. PubMed ID: 25034288
[TBL] [Abstract][Full Text] [Related]
9. Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma.
Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2016 Oct; 31(10):1766-1772. PubMed ID: 26992142
[TBL] [Abstract][Full Text] [Related]
10. Conversion therapy and maintenance therapy for primary hepatocellular carcinoma.
Zhou H; Song T
Biosci Trends; 2021 Jul; 15(3):155-160. PubMed ID: 34039818
[TBL] [Abstract][Full Text] [Related]
11. Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement.
Cheng S; Yang J; Shen F; Zhou W; Wang Y; Cong W; Yang GS; Cheng H; Hu H; Gao C; Guo J; Li A; Meng Y; Jiang X; Yang Y; Qian G; Luo M; Hu B; Man X; Zhang B; Su C; Zhou F; Li N; Shi J; Wang M; Zheng Y; Guo W; Sun J; Wang H; Lau WY; Wu MC
Oncotarget; 2016 Jun; 7(26):40816-40829. PubMed ID: 27027235
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma: diagnosis and treatment.
Befeler AS; Di Bisceglie AM
Gastroenterology; 2002 May; 122(6):1609-19. PubMed ID: 12016426
[TBL] [Abstract][Full Text] [Related]
13. Changes in and challenges regarding the surgical treatment of hepatocellular carcinoma in China.
Liu D; Song T
Biosci Trends; 2021 Jul; 15(3):142-147. PubMed ID: 33716267
[TBL] [Abstract][Full Text] [Related]
14. New concepts in the treatment of hepatocellular carcinoma.
Sidali S; Trépo E; Sutter O; Nault JC
United European Gastroenterol J; 2022 Sep; 10(7):765-774. PubMed ID: 35975347
[TBL] [Abstract][Full Text] [Related]
15. [Expert consensus on transarterial chemoembolization refractoriness and subsequent therapies in hepatocellular carcinoma].
Clinical Guidelines Committee of Chinese College of Interventionalists
Zhonghua Nei Ke Za Zhi; 2022 Aug; 61(8):860-866. PubMed ID: 35922209
[TBL] [Abstract][Full Text] [Related]
16. Indian Council of Medical Research consensus document on hepatocellular carcinoma.
Sirohi B; Shrikhande SV; Gaikwad V; Patel A; Patkar S; Goel M; Bal M; Sharma A; Shrimali RK; Bhatia V; Kulkarni S; Srivastava DN; Kaur T; Dhaliwal RS; Rath GK;
Indian J Med Res; 2020 Nov; 152(5):468-474. PubMed ID: 33707388
[TBL] [Abstract][Full Text] [Related]
17. The size of the problem: clinical algorithms.
Forner A; Bruix J
Dig Dis; 2013; 31(1):95-103. PubMed ID: 23797130
[TBL] [Abstract][Full Text] [Related]
18. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Kwak HW; Park JW; Nam BH; Yu A; Woo SM; Kim TH; Kim SH; Koh YH; Kim HB; Park SJ; Lee WJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2014 Apr; 29(4):820-9. PubMed ID: 24325272
[TBL] [Abstract][Full Text] [Related]
20. Current status of treatment of hepatocellular carcinoma.
Tang ZY
Chin Med J (Engl); 1985 Apr; 98(4):257-64. PubMed ID: 2408825
[No Abstract] [Full Text] [Related]
[Next] [New Search]
